Osaic Holdings
JANX icon

Osaic Holdings’s Janux Therapeutics JANX Stock Holding History

Osaic Holdings’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.06K Buy
436
+158
+57% +$2.17K ﹤0.01% 6585
2025
Q4 		$3.84K Sell
278
-3,512
-93% -$82.6K ﹤0.01% 6838
2025
Q3 		$90.2K Buy
3,790
+322
+9% +$7.84K ﹤0.01% 4877
2025
Q2 		$80.1K Buy
3,468
+3,037
+705% +$80K ﹤0.01% 4680
2025
Q1 		$11.6K Sell
431
-2,804
-87% -$106K ﹤0.01% 5707
2024
Q4 		$173K Buy
3,235
+2,067
+177% +$109K ﹤0.01% 3729
2024
Q3 		$53.1K Buy
1,168
+65
+6% +$2.83K ﹤0.01% 4703
2024
Q2 		$46.2K Buy
1,103
+758
+220% +$35.6K ﹤0.01% 4744
2024
Q1 		$13K Buy
+345
New +$7.51K ﹤0.01% 5610

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Osaic Holdings's JANX Position: Q1 2026 in Review

Osaic Holdings increased its Janux Therapeutics (JANX) stake by 57% in Q1 2026, buying an estimated $2.17K and bringing the position to 436 shares worth $6.06K. The position accounts for ﹤0.01% of the portfolio, ranked #6585.

Osaic Holdings first reported a position in JANX in Q1 2024 and has held it in 9 quarters since. The position peaked at $173K in Q4 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Osaic Holdings held 436 shares of Janux Therapeutics worth $6.06K as of Q1 2026.
  • Osaic Holdings bought 158 Janux Therapeutics shares in Q1 2026, an estimated $2.17K.
  • Janux Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6585 holding.
  • Osaic Holdings first reported a position in Janux Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Osaic Holdings's Janux Therapeutics position peaked at $173K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.